13:37 uur 13-01-2022

Vroege haalbaarheidsstudie toont succesvol gebruik van de preCARDIA-technologie van Abiomed aan

Contacten

Media:
Tom Langford

Directeur Communicatie

+1 (978) 882-8408

tlangford@abiomed.com

Investeerder:
Todd Trapp

Vice President en Chief Financial Officer

+1 (978) 646-1680

ttrapp@abiomed.com

Early feasibility study demonstrates successful use of Abiomed’s preCARDIA technology

Contacts

Media:
Tom Langford

Director of Communications

+1 (978) 882-8408

tlangford@abiomed.com

Investors:
Todd Trapp

Vice President and Chief Financial Officer

+1 (978) 646-1680

ttrapp@abiomed.com

Check out our twitter: @NewsNovumpr